Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer-Reference-Cited by-同舟云学术

Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer

Published:2022-11-22 Issue:22 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Jin Jinmei,Wu Yaping,Zhao Zeng,Wu Ye,Zhou Yu-dong,Liu Sanhong^ORCID,Sun Qingyan,Yang Guizhu,Lin Jiayi,Nagle Dale G.^ORCID,Qin Jiangjiang^ORCID,Zhang Zhiyuan,Chen Hong-zhuan,Zhang Weidong,Sun Shuyang,Luan Xin

Funder

National Natural Science Foundation of China

Shanghai Science and Technology Innovation Action Plan

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

National key subject of drug innovation of China

National key R & D program for key research project of modernization of traditional Chinese medicine

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/160606/files/pdf

Reference62 articles.

1. STAT3 Target Genes Relevant to Human Cancers

2. Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer

3. The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations;Geiger;Oral Oncol,2016

4. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer;Kusaba;Oncol Rep,2006

5. Validating Stat3 in cancer therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

2. Development of natural product-based targeted protein degraders as anticancer agents;Bioorganic Chemistry;2024-12

3. Targeting the STAT3 pathway with STAT3 degraders;Trends in Pharmacological Sciences;2024-09

4. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09

5. Small molecule drug discovery targeting the JAK-STAT pathway;Pharmacological Research;2024-06